Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Sharad Khurana
Assistant Professor, Medicine - (Clinical Scholar Track)
Medicine
Full Page
Overview
Research
More
Collaboration
(17)
Bonnie LaFleur
Mutual work: 2 Proposals
Collaboration Details
Denise Roe
Mutual work: 1 Proposal
Collaboration Details
Megha Padi
Mutual work: 1 Proposal
Collaboration Details
Richard Simpson
Mutual work: 2 Proposals
Collaboration Details
Emmanuel Katsanis
Mutual work: 1 Grant﹒2 Proposals﹒1 Publication
Collaboration Details
Page 1 of 4
Previous page
Next page
Grants
(10)
A Phase 3 Randomized Study Comparing Talquetamab SC in Combination With Daratumumab SC and Pomalidomide (Tai-DP) or Talquetamab SC in Combination With Daratumumab SC (Tal-D) Versus Daratumumab SC, Pom
Active
·
2023
·
$0 / $546.3K
·
External
Co-Investigator (COI)
clinical trials,
immunotherapy,
multiple myeloma,
combination therapy,
drug development
A Phase 1, Multicenter, Open-Label Study of CB-010, a CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)
Active
·
2023
·
$0 / $464.7K
·
External
Co-Investigator (COI)
cell therapy,
cancer treatment,
crispr,
lymphoma,
clinical trial
An Escalation/Expansion, Open Label, Multicenter Study of Iadademstat and Gilteritnib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (R/r Amil) With FMS-like Tyrosine Mutation (FLT3 mu
Active
·
2023
·
$1M / $116.3K
·
External
Principal Investigator (PI)
acute myeloid leukemia,
mutation,
combination therapy,
treatment
A Randomized, Open Label Phase 3 Study Evaluating Safety and Efficacy of Venetoclax in combination with Azacitidine after allogeneic Stem Cell Transplantation in Subjects with Acute Myeloid Leukemia
Active
·
2022
·
$12M / $2.4M
·
External
Principal Investigator (PI)
stem cell transplantation,
acute myeloid leukemia,
venetoclax,
azacitidine,
efficacy and safety
A Phase 1, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral TP-3654 in Patients with Intermediate-2 or High-Risk Primary or Secondary Myelofibrosis
Active
·
2022
·
$252.2K
·
External
Principal Investigator (PI)
pharmacokinetics,
safety,
myelofibrosis,
dose escalation,
pharmacodynamics
Page 1 of 2
Previous page
Next page
Publications
(9)
Recent
Chimeric Antigen Receptor T-Cell CAR T-Cell) Therapy for Primary and Secondary Central Nervous System Lymphoma: A Systematic Review of Literature
2023
cancer immunotherapy,
central nervous system,
lymphoma treatment,
systematic review,
cell therapy
Refractory Pure Red Blood Cell Aplasia Secondary to Major ABO-Incompatible Allogeneic Stem Cell Transplantation Successfully Treated With Daratumumab
2023
stem cell transplantation,
red blood cell aplasia,
daratumumab,
allogeneic transplantation,
refractory treatment
Evaluation of Novel Targets, Including CC-Chemokine Receptor 4, in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma
2023
cancer,
immunotherapy,
leukemia,
targeted therapy,
biomedical research
Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-Analysis
2023
leukemia,
tyrosine kinase inhibitors,
hematopoietic stem cell transplantation,
maintenance therapy,
meta-analysis
Refractory Pure Red Blood Cell Aplasia Secondary to ABO Incompatible Allogeneic Stem Cell Transplant Successfuly Treated with Daratumumab.
2022
stem cell transplant,
red blood cell aplasia,
immunotherapy,
blood type incompatibility,
refractory disease
Feasibility and Efficacy of Partially Replacing Post-Transplantation Cyclophosphamide with Bendamustine in Pediatric and Young Adult Patients Undergoing Haploidentical Bone Marrow Transplantation
2022
bone marrow transplantation,
pediatric patients,
efficacy,
cyclophosphamide,
bendamustine
Impact of COVID-19 in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis
2022
covid-19,
hematopoietic stem cells,
transplant recipients,
systematic review,
meta-analysis
Low-Dose Methotrexate Causing Fatal Pancytopenia in a Patient With Severe Malnutrition
2021
methotrexate,
pancytopenia,
malnutrition,
adverse effects,
patient care
Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
2021
stem cells,
hematopoietic,
transplantation,
graft function,
systematic review